Elsevier

Clinical Therapeutics

Volume 29, Issue 4, April 2007, Pages 711-716
Clinical Therapeutics

Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV

https://doi.org/10.1016/j.clinthera.2007.04.006Get rights and content

Abstract

Background:

Current guidelines and most contemporary statements in the literature indicate that, like other medical conditions, HIV infection requires exceptionally high adherence to highly active antiretroviral therapy (HAART) for successful treatment.

Objective:

This study was conducted to determine the association between pharmacy medication refill rates—a surrogate marker for adherence to HAART— and CD4-count/viral-load responses in patients with HIV

Methods:

This retrospective study was conducted at the HIV Clinic, Veterans Affairs Medical Center, Durham, North Carolina. Male and female patients aged ≥18 years with a history of HIV who attended clinic appointments on 3 consecutive clinic days were enrolled. Pharmacy medication refill-based adherence rates over the 6 months before the study were determined by examining electronic pharmacy records. The most recent viral load and the change (Δ) in CD4 count over the past year-surrogate measures of outcome—were also collected from each patient's electronic medical record and compared with refill adherence rates. The incidence of AIDS-related events and past antiretroviral experience were also compared with the ΔCD4 count and adherence rates.

Results:

Data from 58 patients were included in the study. Thirty-nine patients were black men; the mean age was 51.5 years. There was a nonsignificant correlation between 6-month pharmacy medication refillbased adherence rates and viral loads (r = 0.10). The relationship between ΔCD4 count and adherence was complex. With adherence rates >70%, the ΔCD4 count ranged from +414 to -238, with no indication that increasing adherence led to a greater CD4 count increase. The ΔCD4 count progressively declined with adherence rates ≤70%. Patients' past antiretroviral experience or incidence of AIDS-related events did not significantly affect the distribution of ΔCD4 counts or adherence rates.

Conclusion:

Based on our results, in patients with pharmacy medication refill-based adherence rates >70%, there was no significant correlation between adherence rates and ΔCD4 counts or viral-load responses.

References (21)

  • GrossbergR. et al.

    A time-to-prescription-refill measure of antiretroviral adherence predict ed changes in viral load in HIV

    J Clin Epidemiol.

    (2004)
  • GrossR. et al.

    Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

    AIDS

    (2001)
  • Low-BeerS. et al.

    Adherence to triple therapy and viral load response

    J Acquir Immune Defic Syndr.

    (2000)
  • ChesneyM.

    Adherence to HAART regimens

    AIDS Patient Care STDS

    (2003)
  • PatersonD.L. et al.

    Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

    Ann Intern Med.

    (2000)
  • MaggioloF. et al.

    Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors

    Clin Infect Dis.

    (2005)
  • BangsbergD.R. et al.

    High levels of adherence do not prevent accumulation of HIV drug resistance mutations

    AIDS

    (2003)
  • BangsbergD.R. et al.

    Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates

    J Infect Dis.

    (2004)
  • BangsbergD.R. et al.

    Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

    AIDS

    (2000)
  • NettlesR.E. et al.

    Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring

    Clin Infect Dis.

    (2006)
There are more references available in the full text version of this article.
View full text